BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18022203)

  • 41. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
    Ravna AW; Sylte I; Dahl SG
    J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes.
    Hagan CE; McDevitt RA; Liu Y; Furay AR; Neumaier JF
    Synapse; 2012 Dec; 66(12):1024-34. PubMed ID: 22961814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates.
    Baumann MH; Bulling S; Benaderet TS; Saha K; Ayestas MA; Partilla JS; Ali SF; Stockner T; Rothman RB; Sandtner W; Sitte HH
    Neuropsychopharmacology; 2014 May; 39(6):1355-65. PubMed ID: 24287719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
    Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel serotonin transporter ligand: (5-iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol.
    Zhuang Z; Choi S; Hou C; Mu M; Kung M; Acton PD; Kung HF
    Nucl Med Biol; 2000 Feb; 27(2):169-75. PubMed ID: 10773546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents?
    Karanges E; Li KM; Motbey C; Callaghan PD; Katsifis A; McGregor IS
    Int J Neuropsychopharmacol; 2011 May; 14(4):491-504. PubMed ID: 21329552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
    Cozzi NV; Gopalakrishnan A; Anderson LL; Feih JT; Shulgin AT; Daley PF; Ruoho AE
    J Neural Transm (Vienna); 2009 Dec; 116(12):1591-9. PubMed ID: 19756361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.
    Benmansour S; Cecchi M; Morilak DA; Gerhardt GA; Javors MA; Gould GG; Frazer A
    J Neurosci; 1999 Dec; 19(23):10494-501. PubMed ID: 10575045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine uptake blockers nullify methamphetamine-induced decrease in dopamine uptake and plasma membrane potential in rat striatal synaptosomes.
    Westphalen RI; Stadlin A
    Ann N Y Acad Sci; 2000 Sep; 914():187-93. PubMed ID: 11085320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-dioxin-like PCBs inhibit [(3)H]WIN-35,428 binding to the dopamine transporter: a structure-activity relationship study.
    Wigestrand MB; Stenberg M; Walaas SI; Fonnum F; Andersson PL
    Neurotoxicology; 2013 Dec; 39():18-24. PubMed ID: 23933243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissociable roles of dopamine and serotonin transporter function in a rat model of negative urgency.
    Yates JR; Darna M; Gipson CD; Dwoskin LP; Bardo MT
    Behav Brain Res; 2015 Sep; 291():201-208. PubMed ID: 26005123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immobility responses between mouse strains correlate with distinct hippocampal serotonin transporter protein expression and function.
    Tang M; He T; Meng QY; Broussard JI; Yao L; Diao Y; Sang XB; Liu QP; Liao YJ; Li Y; Zhao S
    Int J Neuropsychopharmacol; 2014 Nov; 17(11):1737-50. PubMed ID: 24833265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaine-induced regulation of striatal dopamine transporter function.
    Mandt BH; Zahniser NR
    Neuropharmacology; 2010 Mar; 58(3):605-12. PubMed ID: 19951714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MPTP-induced neuroblast apoptosis in the subventricular zone is not regulated by dopamine or other monoamine transporters.
    Shibui Y; He XJ; Uchida K; Nakayama H
    Neurotoxicology; 2009 Nov; 30(6):1036-44. PubMed ID: 19616025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.
    Singer A; Wonnemann M; Müller WE
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1363-8. PubMed ID: 10454515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
    Hirano K; Maruyama S; Kimura R; Kagawa Y; Yamada S
    Life Sci; 2004 Oct; 75(24):2933-45. PubMed ID: 15454344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine and serotonin uptake inhibitors on the release of dopamine and serotonin in the nucleus accumbens of young and aged rats.
    Yoshimoto K; Kato B; Ueda S; Noritake K; Sakai K; Shibata M; Hori M; Kawano H; Takeuchi Y; Wakabayashi Y; Yasuhara M
    Mech Ageing Dev; 2001 Oct; 122(15):1707-21. PubMed ID: 11557275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
    Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
    Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.